ANI Pharmaceuticals presents at conference; no new material financial disclosure

ANI PHARMACEUTICALS INC

CEO Nikhil Lalwani presenting at H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20, 2025.
Investor presentation furnished as Exhibit 99.1; no specific financial results or guidance included in the 8-K.
Presentation likely covers corporate overview and recent developments, but details not provided in filing text.

item 2.02item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.